SHANGHAI BIO-HEART BIOLOGICAL TECHNOLOGY CO., LTD.

Andere talen Shanghai Bio-heart Biological Technology Co., Ltd.

Aandelen

2185

CNE100004JH3

Beurs gesloten - Hong Kong S.E. Andere beurzen 10:08:22 20-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,91 ^HKD	-7,73%		-7,73%	-44,15%

22/05	Shanghai Bio-Heart Biological Technology Co. Kondigt ontslag aan van Raad van Bestuur en Comité	CI
25/03	Shanghai Bio-heart Biological Technology Co, Ltd. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Shanghai Bio-Heart Biological Technology Co., Ltd. Announces Board and Committee Resignations	22/05
Shanghai Bio-heart Biological Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	25/03
Shanghai Bio-Heart Biological Technology Co., Ltd. Announces Change of Employee Representative Supervisor	31-08-23
Shanghai Bio-heart Biological Technology's Loss Narrows in H1	14-08-23
Shanghai Bio-heart Biological Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	11-08-23
Bioheart (02185.HK) announces clinical result for Iberis-HTN at CIT 2023	30-06-23
Bioheart Announces Clinical Result for Iberis-Htn At Cit 2023	30-06-23
Shanghai Bio-heart Biological Technology Co., Ltd. Announces Management Changes	26-06-23
Shanghai Bio-heart Injects 15 Million Yuan Into Medical Device Developer Xinzhi Medical; Shares Surge 17%	17-04-23
Shanghai Xinzhi Medical Technology Co., Ltd. announced that it expects to receive CNY 15 million in funding from Shanghai Bio-heart Biological Technology Co., Ltd.	14-04-23
Shanghai Bio-heart Biological Technology Achieves Primary Clinical Endpoint for Catheter System; Shares Climb 44%	12-04-23
Shanghai Bio-heart Biological Technology Co., Ltd. Announces Achievement of Primary Clinical Endpoint in the Iberis-HTN	11-04-23
Shanghai Bio-Heart Biological Technology Co., Ltd. Announces Ji Chen Would Not Offer Himself for Re-Election as A Non-Executive Director	31-03-23
Shanghai Bio-heart Biological Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	31-03-23
Shanghai Bio-heart Biological Technology Co., Ltd. Announces First Patient Enrollment in the RADIUS-HTN Trial	27-03-23
Shanghai Bio-heart Biological Technology Co., Ltd.(SEHK:2185) dropped from S&P Global BMI Index	20-03-23
Certain H Shares of Shanghai Bio-heart Biological Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 23-DEC-2022.	23-12-22
Shanghai Bio-heart to Conduct Clinical Trials in Japan for Restenosis Treatment	18-11-22
Shanghai Bio-Heart Biological Technology Co., Ltd. Announces Clinical Trial of Sirolimus Drug-Eluting Balloon for the Treatment of In-Stent Restenosis	17-11-22
Shanghai Bio-Heart Biological Technology Co., Ltd. Announces Its Iberis® multi-electrode RDN system product Approve by the Ethics Committee of Ruijin Hainan Hospital	17-11-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Shanghai Bio-heart Biological Technology Co., Ltd.

Aandelen

2185

CNE100004JH3

Andere talen

Filters